PMID- 11912248 OWN - NLM STAT- MEDLINE DCOM- 20020819 LR - 20210513 IS - 1046-6673 (Print) IS - 1046-6673 (Linking) VI - 13 IP - 4 DP - 2002 Apr TI - Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. PG - 894-902 LID - 10.1681/ASN.V134894 [doi] AB - Although high glucose (HG) has been shown to induce nuclear factor-kappaB (NF-kappaB) activation in vascular cells, the upstream regulation and the biologic significance of NF-kappaB activation in diabetic renal injury are not clear. It was, therefore, examined if HG-induced generation of reactive oxygen species (ROS) and protein kinase C (PKC) activation are involved in NF-kappaB activation in mesangial cells (MC), and the role of NF-kappaB activation in HG-induced monocyte chemoattractant protein-1 (MCP-1) expression by MC was further investigated. Recent observations suggest that MCP-1 may play a role in the development and progression of diabetic nephropathy. HG rapidly induced NF-kappaB activation in MC as estimated by electrophoretic mobility shift assay. Supershift assay suggests that most of the binding activity arose from p50/p50 and p50/p65 dimers. Antioxidants, pyrrolidine dithiocarbamate, N-acetyl-L-cystein, and trolox effectively inhibited HG-induced NF-kappaB activation in MC. HG rapidly generated dichlorofluorescin-sensitive intracellular ROS in MC as measured by laser-scanning confocal microscopy. HG also activated PKC rapidly in MC. Inhibition of PKC effectively blocked HG-induced intracellular ROS generation and NF-kappaB activation in MC. HG increased MCP-1 mRNA expression by 1.9-fold and protein secretion by 1.6-fold that of control glucose in MC transfected with control vector but not in MC transfected with dominant negative mutant inhibitor of NF-kappaB (IkappaBalphaM). Inhibition of either PKC or ROS effectively blocked HG-induced, but not basal, MCP-1 protein secretion by MC transfected with control vector. Thus this study demonstrates that HG rapidly activates NF-kappaB in MC through PKC and ROS and suggests that HG-induced NF-kappaB activation in MC may play a role in diabetic renal injury through upregulation of MCP-1 mRNA and protein expression. FAU - Ha, Hunjoo AU - Ha H AD - *Hyonam Kidney Laboratory, Soon Chun Hyang University, Seoul, Korea; and daggerUniversity College London Medical School, The Rayne Institute, London, United Kingdom. FAU - Yu, Mi Ra AU - Yu MR AD - *Hyonam Kidney Laboratory, Soon Chun Hyang University, Seoul, Korea; and daggerUniversity College London Medical School, The Rayne Institute, London, United Kingdom. FAU - Choi, Yoon Jin AU - Choi YJ AD - *Hyonam Kidney Laboratory, Soon Chun Hyang University, Seoul, Korea; and daggerUniversity College London Medical School, The Rayne Institute, London, United Kingdom. FAU - Kitamura, Masanori AU - Kitamura M AD - *Hyonam Kidney Laboratory, Soon Chun Hyang University, Seoul, Korea; and daggerUniversity College London Medical School, The Rayne Institute, London, United Kingdom. FAU - Lee, Hi Bahl AU - Lee HB AD - *Hyonam Kidney Laboratory, Soon Chun Hyang University, Seoul, Korea; and daggerUniversity College London Medical School, The Rayne Institute, London, United Kingdom. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Am Soc Nephrol JT - Journal of the American Society of Nephrology : JASN JID - 9013836 RN - 0 (Antioxidants) RN - 0 (Chemokine CCL2) RN - 0 (Enzyme Inhibitors) RN - 0 (NF-kappa B) RN - 0 (RNA, Messenger) RN - 0 (Reactive Oxygen Species) RN - EC 2.7.11.13 (Protein Kinase C) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Animals MH - Antioxidants/pharmacology MH - Cells, Cultured MH - Chemokine CCL2/genetics/*metabolism MH - Dose-Response Relationship, Drug MH - Enzyme Inhibitors/pharmacology MH - Glomerular Mesangium/cytology/drug effects/*metabolism MH - Glucose/*administration & dosage/pharmacology MH - Intracellular Membranes/metabolism MH - Mice MH - NF-kappa B/*physiology MH - Protein Kinase C/antagonists & inhibitors/physiology MH - RNA, Messenger/metabolism MH - Reactive Oxygen Species/metabolism EDAT- 2002/03/26 10:00 MHDA- 2002/08/20 10:01 CRDT- 2002/03/26 10:00 PHST- 2002/03/26 10:00 [pubmed] PHST- 2002/08/20 10:01 [medline] PHST- 2002/03/26 10:00 [entrez] AID - 13/4/894 [pii] AID - 10.1681/ASN.V134894 [doi] PST - ppublish SO - J Am Soc Nephrol. 2002 Apr;13(4):894-902. doi: 10.1681/ASN.V134894.